Implementing screening for Lynch syndrome among patients with newly diagnosed colorectal cancer: summary of a public health/clinical collaborative meeting

@article{Bellcross2012ImplementingSF,
  title={Implementing screening for Lynch syndrome among patients with newly diagnosed colorectal cancer: summary of a public health/clinical collaborative meeting},
  author={Cecelia A. Bellcross and Sara R. Bedrosian and Elvan Daniels and Debra Duquette and Heather Hampel and Kory W. Jasperson and Djenaba A. Joseph and Celia Kaye and Ira M. Lubin and Laurence J. Meyer and Michele Reyes and Maren T Scheuner and Sheri D Schully and Leigha A. Senter and Sherri L. Stewart and Jeanette St. Pierre and Judith A. Westman and P. Gail Wise and Vincent W. Yang and Muin J. Khoury},
  journal={Genetics in Medicine},
  year={2012},
  volume={14},
  pages={152-162}
}
Lynch syndrome is the most common cause of inherited colorectal cancer, accounting for approximately 3% of all colorectal cancer cases in the United States. In 2009, an evidence-based review process conducted by the independent Evaluation of Genomic Applications in Practice and Prevention Working Group resulted in a recommendation to offer genetic testing for Lynch syndrome to all individuals with newly diagnosed colorectal cancer, with the intent of reducing morbidity and mortality in family… CONTINUE READING